ClinicalTrials.gov
public full text
Public Domain
Hepatitis A Vaccine in Patients With Immunomodulating Drugs
Hepatitis A vaccine is the most frequently used traveller's vaccine, yet data on its ability to induce protective immunity in immunosuppressed travellers are scarce. The investigators assess the hepatitis A virus (HAV) antibody response in patients with rheumatoid arthritis (RA) treated with Tumor Necrosis Factor (TNF) - inhibitors and/or methotrexate (Mtx).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- MF59-adjuvanted Influenza Vaccine and 23-valent Pneumococcal Polysaccharide Vaccine#897847
- Safety and Efficacy Study of Adjuvanted Prophylactic Hepatitis B Vaccine#828177
- Minor Histocompatibility Vaccination After Allogeneic Stem Cell Transplantation for Advanced Hematologic Malignancies#840007
- Antiviral Efficacy of the Combination Treatment With Poly IC and Entecavir for Chronic Hepatitis B#843197
- Human Immune Responses to Yellow Fever Vaccination#1009756
Record · ID 827703
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive